Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-011988

Options or other derivatives

  • CHIEF OPERATING OFFICER acquired 26,543 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Tessari Eben CHIEF OPERATING OFFICER 2025-05-01 Grant or award · Performance Share Unit +4,975 4,975 D: show line 1 in the form
Tessari Eben CHIEF OPERATING OFFICER 2025-05-01 Grant or award · Performance Share Unit +5,224 5,224 D: show line 2 in the form
Tessari Eben CHIEF OPERATING OFFICER 2025-05-01 Grant or award · Performance Share Option +8,042 8,042 D: show line 3 in the form
Tessari Eben CHIEF OPERATING OFFICER 2025-05-01 Grant or award · Performance Share Option +8,302 8,302 D: show line 4 in the form
Loading xslF345X05/form4-05052025_080511.xml…